Dongjoon Ko

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Cooperation between ZEB2 and SP1 upregulates PD‑L1 and CCL2 to promote the immunosuppressive activity of tumor cells.

Cooperation between ZEB2 and SP1 upregulates PD‑L1 and CCL2 to promote the immunosuppressive activity of tumor cells.

Journal: International journal of oncology

Published: February 26, 2025

TMEM52B-derived peptides inhibit generation of soluble E-cadherin and EGFR activity to suppress colon cancer growth and early metastasis.

TMEM52B-derived peptides inhibit generation of soluble E-cadherin and EGFR activity to suppress colon cancer growth and early metastasis.

Journal: Journal of translational medicine

Published: August 27, 2024

Bioconjugated Thymol-Zinc Oxide Nanocomposite as a Selective and Biocompatible Antibacterial Agent against Staphylococcus Species.

Bioconjugated Thymol-Zinc Oxide Nanocomposite as a Selective and Biocompatible Antibacterial Agent against Staphylococcus Species.

Journal: International journal of molecular sciences

Published: May 13, 2022

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models.

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models.

Journal: Molecular therapy oncolytics

Published: August 27, 2021

TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.

TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 28, 2021

Bovine Serum Albumin-Immobilized Black Phosphorus-Based γ-Fe2O3 Nanocomposites: A Promising Biocompatible Nanoplatform.

Bovine Serum Albumin-Immobilized Black Phosphorus-Based γ-Fe2O3 Nanocomposites: A Promising Biocompatible Nanoplatform.

Journal: Biomedicines

Published: June 22, 2021

TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity.

TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 06, 2020

Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4.

Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4.

Journal: Scientific reports

Published: November 27, 2018

Cooperation between ZEB2 and Sp1 promotes cancer cell survival and angiogenesis during metastasis through induction of survivin and VEGF.

Cooperation between ZEB2 and Sp1 promotes cancer cell survival and angiogenesis during metastasis through induction of survivin and VEGF.

Journal: Oncotarget

Published: June 07, 2017

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.

Journal: Theranostics

Published: March 23, 2016

TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.

TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.

Journal: Oncotarget

Published: July 29, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026